Dual-Track Cell Therapy Innovator Secures Angel Funding for Human and Pet-Derived Therapeutics, Files for IPO
Jan 28, 2026 16:55
CST Updated
16:55
Bright Biotechnology
Developer of Stem Cell and Immune Cell Technologies
